Below are the most recent publications written about "Lymphoproliferative Disorders" by people in Profiles.
-
Chen JH, Arceri T, Datta R, Sullivan KE. Delayed post-COVID-19 hemophagocytic lymphohistiocytosis in patient with XIAP deficiency. Pediatr Allergy Immunol. 2023 09; 34(9):e14028.
-
Yakaboski E, Fuleihan RL, Sullivan KE, Cunningham-Rundles C, Feuille E. Lymphoproliferative Disease in CVID: a Report of Types and Frequencies from a US Patient Registry. J Clin Immunol. 2020 04; 40(3):524-530.
-
Piccolo V, Russo T, Agozzino M, Vitiello P, Caccavale S, Alfano R, Argenziano G. Dermoscopy of Cutaneous Lymphoproliferative Disorders: Where Are We Now? Dermatology. 2018; 234(3-4):131-136.
-
Kelsen JR, Dawany N, Martinez A, Martinez A, Grochowski CM, Maurer K, Rappaport E, Piccoli DA, Baldassano RN, Mamula P, Sullivan KE, Devoto M. A de novo whole gene deletion of XIAP detected by exome sequencing analysis in very early onset inflammatory bowel disease: a case report. BMC Gastroenterol. 2015 Nov 18; 15:160.
-
Noh TK, Haw S, Soung JH, Won CH, Chang S, Choi JH, Moon KC, Park YS, Lee MW. Systemic lupus erythematous presenting with hydroa vacciniforme-like eruption: mimicking Epstein-Barr virus-associated lymphoproliferative disorders. J Dermatol. 2012 Dec; 39(12):1095-7.
-
Teachey DT, Obzut DA, Axsom K, Choi JK, Goldsmith KC, Hall J, Hulitt J, Manno CS, Maris JM, Rhodin N, Sullivan KE, Brown VI, Grupp SA. Rapamycin improves lymphoproliferative disease in murine autoimmune lymphoproliferative syndrome (ALPS). Blood. 2006 Sep 15; 108(6):1965-71.
-
Filipovich A, Conley ME, Nichols KE, Sullivan KE. X-linked lymphoproliferative syndrome: an X-cellent question. Clin Immunol. 2006 Jun; 119(3):241-4.
-
Teachey DT, Manno CS, Axsom KM, Andrews T, Choi JK, Greenbaum BH, McMann JM, Sullivan KE, Travis SF, Grupp SA. Unmasking Evans syndrome: T-cell phenotype and apoptotic response reveal autoimmune lymphoproliferative syndrome (ALPS). Blood. 2005 Mar 15; 105(6):2443-8.
-
Arulanandam BP, Raeder RH, Nedrud JG, Bucher DJ, Le J, Metzger DW. IgA immunodeficiency leads to inadequate Th cell priming and increased susceptibility to influenza virus infection. J Immunol. 2001 Jan 01; 166(1):226-31.
-
Takada M, Murata M, Takei M, Nakagawa S, Okumura H, Kawamura A. The rescue of Epstein--Barr virus from primary cultured cells of nasopharyngeal carcinoma. Comp Immunol Microbiol Infect Dis. 1979; 2(2-3):177-89.